BDTX Black Diamond Therapeutics
- 3.440
- -0.110-3.10%
- 3.499
- +0.059+1.72%
Black Diamond Therapeutics News
Black Diamond Therapeutics | 8-K: Current report
Black Diamond Therapeutics | 8-K: Current report
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Behbahani Ali
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Campbell Shannon
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Raman Prakash
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Versant Venture Capital VI, L.P.
Black Diamond Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Versant Ventures VI GP, L.P.(7.7%),Versant Ventures VI GP-GP, LLC(7.7%), etc.
Black Diamond Therapeutics | 10-Q: Q2 2024 Earnings Report
Black Diamond Therapeutics | 8-K: Black Diamond Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Black Diamond Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Black Diamond Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Black Diamond Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Black Diamond Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Black Diamond Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. Rowe Price Investment Management, Inc.(18.9%)
Black Diamond Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Black Diamond Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Black Diamond Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Black Diamond Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Black Diamond Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Black Diamond Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Analysis
Price Target
No Data
No Data